New twists in the pharmacology of NSAID drugs

C. Buccellati, E. Selg, M. Andersson, G. Rovati, M. Ezinga, A. Sala, A. K. Larsson, E. Ambrosio, L. Lastbom, V. Capra, B. Dahlen, A. Ryrfeldt, S. E. Dahlen, G. Folco (Milan, Italy; Stockholm, Sweden)

Source: Annual Congress 2007 - Recent advances in our understanding of the mechanisms of asthma treatment
Session: Recent advances in our understanding of the mechanisms of asthma treatment
Session type: Thematic Poster Session
Number: 2160
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Buccellati, E. Selg, M. Andersson, G. Rovati, M. Ezinga, A. Sala, A. K. Larsson, E. Ambrosio, L. Lastbom, V. Capra, B. Dahlen, A. Ryrfeldt, S. E. Dahlen, G. Folco (Milan, Italy; Stockholm, Sweden). New twists in the pharmacology of NSAID drugs. Eur Respir J 2007; 30: Suppl. 51, 2160

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
New and repurposed drugs
Source: Eur Respir Monogr 2018; 82: 179-204
Year: 2018


New anti-tuberculosis drugs for special populations: a difficult-to-address issue
Source: Eur Respir J 2016; 48: 957-958
Year: 2016


Drugs anti-inflammatories
Source: Virtual Congress 2020 – Management
Year: 2020


New and repurposed drugs for MDR-TB patients
Source: International Congress 2017 – PG2 Multidrug-resistant tuberculosis management in settings with a low tuberculosis incidence 
Year: 2017


New anti-tuberculosis drugs and regimens: 2015 update
Source: ERJ Open Res 2015; 1: 00010-2015
Year: 2015



Anti-tuberculosis drugs
Source: International Congress 2017 – State of the art session: "Respiratory infections"
Year: 2017


Prospects for new compounds tiosemikarbazonami class to create drugs with antituberculosis activity
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014

Novel anti-inflammatory agents
Source: Annual Congress 2009 - Emerging trends in the therapy of COPD
Year: 2009


Facts and perspectives in the development of new anti-TB drugs
Source: Annual Congress 2008 - New insights into tuberculosis control
Year: 2008


New researches on teratogenic and embryogenotoxic effects of tiotropium
Source: Eur Respir J 2005; 26: Suppl. 49, 121s
Year: 2005

New antibiotics into clinical practice
Source: Annual Congress 2004 - PG18 - Childhood pneumonia after the turn of the new millennium
Year: 2004


Availability of anti-tuberculosis drugs in Europe
Source: Eur Respir J 2012; 40: 500-503
Year: 2012


Emerging inhaled bronchodilators: an update
Source: Eur Respir J 2009; 34: 757
Year: 2009



New bronchodilators
Source: Annual Congress 2012 - The promise of new drugs for treating asthma and COPD
Year: 2012


New targets for drug development in asthma
Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium
Year: 2008


New ways of using nicotine
Source: International Congress 2019 – Spanish/Portuguese programme 2019: Part II
Year: 2019